GL1X · GenesisL1 explorer

Research workbench

Free structure of an anti-methotrexate CDR1-4 graft vhh antibody

Analyse Free structure of an anti-methotrexate CDR1-4 graft vhh antibody in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3QXW
Type
protein
Length
614 residues
Chains
5
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Anti-methotrexate CDR1-4 graft vhh
Ligands
NA, SO4
Pockets
4 · best druggability 0.59

Structure

x-ray diffraction · 3 distinct chains · 8% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, EAnti-methotrexate CDR1-4 graft vhhprotein12412% helix, 48% strand—
CAnti-methotrexate CDR1-4 graft vhhprotein1195% helix, 49% strand—
DAnti-methotrexate CDR1-4 graft vhhprotein1238% helix, 48% strand—

Ligands and binding sites

  • NA · Sodium ion · metal · chains B, D
  • SO4 · Sulfate ion · ion · 2 copies · chains D, E

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13400.590.7731empty
23270.570.7636empty
33000.560.7733SO4
4970.360.7514empty

Interfaces

4 interfaces between chains.

  • A–C · 420 Ų buried · 5 hydrogen bonds · protein-protein
  • B–D · 415 Ų buried · 5 hydrogen bonds · protein-protein
  • C–E · 377 Ų buried · 5 hydrogen bonds · protein-protein
  • A–D · 290 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 3QXW · Free structure of an anti-methotrexate CDR1-4 Graft VHH Antibody · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.